Dak Gesundheit Intends Tender

🏛️ Dak-Gesundheit
📄 Tender ID: 97496005 📅 Published: 17 Jun 2026

📋 Tender Overview

The DAK-Gesundheit intends to conclude a non-exclusive discount agreement for the active ingredient Omalizumab, ATC L04AG08, for the period from 01.08.2026 to 31.07.2028. This procedure is based on the absence of a selection decision, allowing all pharmaceutical companies to participate without discrimination. The agreement will automatically end upon the commencement of an exclusive contract for the active ingredient Omalizumab. The DAK-Gesundheit aims to establish discount agreements with as many interested pharmaceutical companies as possible until new discount agreements for medicines come into effect. Omalizumab, ATC L04AG08

🔍 Key Information

📄
Tender Reference No.
97496005
📅
Publication Date
17 Jun 2026
💰
Estimated Value
N/A
🌐
Sector
N/A
📅
Deadline
14 Dec 2026
📝
Notice Type
Tenders
📍
Location
Germany
📑
Contract Duration
5 Months 27 Days

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
25
days remaining · 14 Dec 2026
🔔 Set Alert

🧭 Quick Facts

Authority Dak-Gesundheit
Country Germany
State / UT N/A
Tender Type Tender Notice
Currency N/A
Similar Tenders
Loading similar tenders…